Phase 3, Open-Label Study to Characerize the Incidence and Severity of Diarrhea in Patients with Early stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis - Regional Cancer Care Associates LLC

Clinical Trials

Phase 3, Open-Label Study to Characerize the Incidence and Severity of Diarrhea in Patients with Early stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis

Type of Cancer
Breast Oncology
Locations
Howell
Sponsor
PUMA
Protocol Number
PUMA-NER-1301
Cancer Diagnosis
To Learn More Call
201-510-0910